Advanced Enzyme Technologies Q2 FY27: revenue up 16.2% to ₹215 Cr, net profit up 11.5% to ₹48 Cr
Results · Finvezto · 3 Nov 2026 · Advanced Enzyme Technologies (ADVENZYMES)
Results Q2 FY27, ₹ Cr
| Q2 FY27 | ₹ Cr | QoQ | YoY |
|---|---|---|---|
| Revenue | 215 | - | +16.2% |
| Operating profit | 72 | - | +20.1% |
| Net profit | 48 | - | +11.5% |
| Operating margin | 33.6% | - | +1.1 pp |
| Net margin | 22.5% | - | -0.9 pp |
YoY is the company's own figure. QoQ shows where our quarterly series matches the filing.
Key points
- Revenue for Q2 FY27 increased 16% year-on-year and 12% sequentially to INR 2,145 million, with first half FY27 revenue growing 10% to INR 4,062 million. Earnings call
- EBITDA grew 20% year-on-year to INR 721 million with an EBITDA margin of 34%, while profit after tax rose 14% year-on-year to INR 512 million. Earnings call
- Segment revenue grew across all verticals in Q2 FY27, led by Bio-Processing at 43%, Animal Healthcare at 37%, Specialized Manufacturing at 25%, and Human Healthcare at 6%. Earnings call
What to watch
- Management on capex: Yes. So that's the same thing as of now.
- Management on ebitda margin: It's a difficult question at this point of time to answer because a lot of things depends how it moves, but we will continue as our guidelines, which we say that between 30% to 32% on an overall basis.
Links
Company page · Results tracker
Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.